Maze Therapeutics, Inc. (MAZE) has a market capitalization of $1.38B and trades at $27.68. The 52-week range is 6.71-53.65.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -9.1, Earnings Per Share (EPS) of $-3.05.
The stock has a beta of 4.47, operates in the Healthcare sector.
